Aligos TherapeuticsALGS
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 33 institutions reported holding Aligos Therapeutics Inc. (ALGS) in their 13F filings, down 4 from Q2 2025. 6 opened new positions and 9 sold out. The largest holders were Woodline Partners LP ($4.6M), Deep Track Capital, LP ($4.4M) and Alyeska Investment Group, L.P. ($4.0M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aligos Therapeutics Inc.
- CUSIP
- 01626L204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $215K |
| Exits | 9 | $1.5M |
All 13F filers, Q2 2025 → Q3 2025: 221,748 shares bought and 276,313 shares sold, net −54,565 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Woodline Partners LP | 0.02% | Reduce -9.7% | 468,199 | $4.6M |
| Deep Track Capital, LP | 0.12% | No change | 444,110 | $4.4M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 412,000 | $4.0M |
| Sio Capital Management, LLC | 0.83% | No change | 335,937 | $3.3M |
| Readystate Asset Management LP | 0.19% | Add +48.5% | 203,113 | $2.0M |
| Vanguard Group Inc. | 0.00% | Add +22.8% | 171,689 | $1.7M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 140,000 | $1.4M |
| Baker Bros. Advisors LP | 0.01% | No change | 83,055 | $814K |
| HHLR Advisors, LTD. | 0.02% | No change | 76,247 | $747K |
| LPL Financial LLC | 0.00% | Add +83.1% | 55,120 | $540K |
| Renaissance Technologies | 0.00% | Add +4.7% | 55,019 | $539K |
| Geode Capital Management, LLC | 0.00% | Add +38.3% | 47,080 | $462K |
| Two Sigma Investments, LP | 0.00% | Add +223.0% | 38,995 | $382K |
| Squarepoint Ops LLC | 0.00% | Add +64.0% | 30,493 | $299K |
| UBS Group AG | 0.00% | Add +489.9% | 16,182 | $159K |
| BlackRock, Inc. | 0.00% | No change | 13,040 | $128K |
| Morgan Stanley | 0.00% | Add +181.8% | 11,284 | $111K |
| Citadel Advisors | 0.00% | Reduce -32.2% | 10,310 | $101K |
| Susquehanna International Group, LLP | 0.00% | New | 10,107 | $99K |
| NorthCrest Asset Manangement, LLC | 0.00% | New | 10,000 | $98K |
| AlphaQuest LLC | 0.00% | Add +13.9% | 6,772 | $66K |
| Wells Fargo & Company | 0.00% | Reduce -77.0% | 3,170 | $31K |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,674 | $26K |
| Royal Bank of Canada | 0.00% | No change | 2,125 | $21K |
| Bank of America Corp. | 0.00% | Reduce -26.7% | 1,914 | $19K |
| Rockefeller Capital Management L.P. | 0.00% | New | 1,000 | $10K |
| Global Retirement Partners, LLC | 0.00% | New | 800 | $8K |
| JPMorgan Chase & Co. | 0.00% | Add +2623.1% | 708 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -58.6% | 457 | $4K |
| SBI Securities Co., Ltd. | 0.00% | No change | 26 | $255 |
| Barclays PLC | 0.00% | New | 15 | $147 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 4 | $40 |
| BNP Paribas Financial Markets | 0.00% | Reduce -99.8% | 3 | $29 |
"% of holder's portfolio" is ALGS's weight in each manager's 13F, not the share of Aligos Therapeutics Inc. the manager owns.